{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T03:50:35Z","timestamp":1743047435748,"version":"3.40.3"},"publisher-location":"Cham","reference-count":64,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031646355"},{"type":"electronic","value":"9783031646362"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-64636-2_25","type":"book-chapter","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:02:27Z","timestamp":1724738547000},"page":"329-342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the Construction and Application of Engineering Bacteria"],"prefix":"10.1007","author":[{"given":"Zihan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"25_CR1","doi-asserted-by":"crossref","first-page":"997587","DOI":"10.3389\/fmicb.2022.997587","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y., et al.: Genetically engineered bacterium: principles, practices, and prospects. Front. Microbiol. 13, 997587 (2022)","journal-title":"Front. Microbiol."},{"key":"25_CR2","doi-asserted-by":"crossref","unstructured":"Adams, B., The next generation of synthetic biology chassis: moving synthetic biology from the laboratory to the field. ACS Syn. Biol. 5  (2016)","DOI":"10.1021\/acssynbio.6b00256"},{"issue":"11","key":"25_CR3","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2174\/1389201024666221220113517","volume":"24","author":"PL Patil","year":"2023","unstructured":"Patil, P.L., et al.: Engineered bacteria: general overview as therapeutic agent and a novel drug delivery system. Curr. Pharm. Biotechnol. 24(11), 1351\u20131364 (2023)","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"4","key":"25_CR4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrmicro.2017.172","volume":"16","author":"DT Riglar","year":"2018","unstructured":"Riglar, D.T., Silver, P.A.: Engineering bacteria for diagnostic and therapeutic applications. Nat. Rev. Microbiol. 16(4), 214\u2013225 (2018)","journal-title":"Nat. Rev. Microbiol."},{"key":"25_CR5","doi-asserted-by":"crossref","unstructured":"Mugwanda, K., et al.: Recent advances in genetic tools for engineering probiotic lactic acid bacteria. Biosci Rep. 43(1) (2023)","DOI":"10.1042\/BSR20211299"},{"issue":"5","key":"25_CR6","doi-asserted-by":"crossref","first-page":"17057","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole, P.W., Marchesi, J.R., Hill, C.: Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2(5), 17057 (2017)","journal-title":"Nat. Microbiol."},{"key":"25_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-chembioeng-061312-103351","volume":"4","author":"YH Wang","year":"2013","unstructured":"Wang, Y.H., Wei, K.Y., Smolke, C.D.: Synthetic biology: advancing the design of diverse genetic systems. Ann. Rev. Chem. Biomol. Eng. 4, 69\u2013102 (2013)","journal-title":"Ann. Rev. Chem. Biomol. Eng."},{"key":"25_CR8","doi-asserted-by":"crossref","unstructured":"Hamidi Nia, L., Claesen, J.: Engineered cancer targeting microbes and encapsulation devices for human gut microbiome applications. Biochemistry 61(24), 2841\u20132848 (2022)","DOI":"10.1021\/acs.biochem.2c00251"},{"issue":"3","key":"25_CR9","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","volume":"8","author":"JM Kocarnik","year":"2022","unstructured":"Kocarnik, J.M., et al.: Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 8(3), 420\u2013444 (2022)","journal-title":"JAMA Oncol."},{"issue":"2","key":"25_CR10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/db15-1625","volume":"66","author":"T Takiishi","year":"2017","unstructured":"Takiishi, T., et al.: Reversal of diabetes in NOD mice by clinical-grade proinsulin and IL-10-secreting lactococcus lactis in combination with low-dose anti-CD3 depends on the induction of foxp3-positive T Cells. Diabetes 66(2), 448\u2013459 (2017)","journal-title":"Diabetes"},{"issue":"9","key":"25_CR11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella, V.M., et al.: Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat. Biotechnol. 36(9), 857\u2013864 (2018)","journal-title":"Nat. Biotechnol."},{"issue":"5","key":"25_CR12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1042\/ETLS20190096","volume":"3","author":"T Harimoto","year":"2019","unstructured":"Harimoto, T., Danino, T.: Engineering bacteria for cancer therapy. Emerg. Top Life Sci. 3(5), 623\u2013629 (2019)","journal-title":"Emerg. Top Life Sci."},{"key":"25_CR13","doi-asserted-by":"crossref","first-page":"2397808","DOI":"10.1155\/2018\/2397808","volume":"2018","author":"K \u0141ukasiewicz","year":"2018","unstructured":"\u0141ukasiewicz, K., Fol, M.: Microorganisms in the treatment of cancer: advantages and limitations. J. Immunol. Res. 2018, 2397808 (2018)","journal-title":"J. Immunol. Res."},{"issue":"11","key":"25_CR14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","volume":"10","author":"NS Forbes","year":"2010","unstructured":"Forbes, N.S.: Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10(11), 785\u2013794 (2010)","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"25_CR15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1751-7915.13292","volume":"12","author":"P Calero","year":"2019","unstructured":"Calero, P., Nikel, P.I.: Chasing bacterial chassis for metabolic engineering: a perspective review from classical to non-traditional microorganisms. Microb. Biotechnol. 12(1), 98\u2013124 (2019)","journal-title":"Microb. Biotechnol."},{"issue":"4","key":"25_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/EBC20160015","volume":"60","author":"J Kim","year":"2016","unstructured":"Kim, J., et al.: Properties of alternative microbial hosts used in synthetic biology: towards the design of a modular chassis. Essays Biochem. 60(4), 303\u2013313 (2016)","journal-title":"Essays Biochem."},{"issue":"1","key":"25_CR17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/1751-7915.13318","volume":"12","author":"LC Nora","year":"2019","unstructured":"Nora, L.C., et al.: The art of vector engineering: towards the construction of next-generation genetic tools. Microb. Biotechnol. 12(1), 125\u2013147 (2019)","journal-title":"Microb. Biotechnol."},{"issue":"6","key":"25_CR18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1021\/acssynbio.0c00008","volume":"9","author":"T Mukai","year":"2020","unstructured":"Mukai, T., et al.: Overcoming the challenges of megabase-sized plasmid construction in escherichia coli. ACS Synth. Biol. 9(6), 1315\u20131327 (2020)","journal-title":"ACS Synth. Biol."},{"key":"25_CR19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fmicb.2014.00021","volume":"5","author":"C Elena","year":"2014","unstructured":"Elena, C., et al.: Expression of codon optimized genes in microbial systems: current industrial applications and perspectives. Front. Microbiol. 5, 21 (2014)","journal-title":"Front. Microbiol."},{"issue":"8","key":"25_CR20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","volume":"40","author":"T Harimoto","year":"2022","unstructured":"Harimoto, T., et al.: A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat. Biotechnol. 40(8), 1259\u20131269 (2022)","journal-title":"Nat. Biotechnol."},{"key":"25_CR21","doi-asserted-by":"crossref","first-page":"107438","DOI":"10.1016\/j.foodhyd.2021.107438","volume":"125","author":"Z Jiang","year":"2022","unstructured":"Jiang, Z., et al.: Recent advances in the design and fabrication of probiotic delivery systems to target intestinal inflammation. Food Hydrocolloids 125, 107438 (2022)","journal-title":"Food Hydrocolloids"},{"key":"25_CR22","doi-asserted-by":"crossref","first-page":"122246","DOI":"10.1016\/j.biomaterials.2023.122246","volume":"301","author":"S Aghlara-Fotovat","year":"2023","unstructured":"Aghlara-Fotovat, S., et al.: Hydrogel-encapsulation to enhance bacterial diagnosis of colon inflammation. Biomaterials 301, 122246 (2023)","journal-title":"Biomaterials"},{"key":"25_CR23","doi-asserted-by":"crossref","unstructured":"Pantoja Angles, A., et al.: Microbial biocontainment systems for clinical, agricultural, and industrial applications 10 (2022)","DOI":"10.3389\/fbioe.2022.830200"},{"key":"25_CR24","unstructured":"He, W., et al.: Cancer treatment evolution from traditional methods to stem cells and gene therapy. Current Gene Therapy 21 (2021)"},{"key":"25_CR25","doi-asserted-by":"crossref","unstructured":"Arruebo, M., et al.: Assessment of the Evolution of Cancer Treatment Therapies. 3(3), 3279\u20133330 (2011)","DOI":"10.3390\/cancers3033279"},{"key":"25_CR26","doi-asserted-by":"crossref","unstructured":"Huang, X., et al.: Bacteria-based cancer immunotherapy. Adv. Sci. (Weinh) 8(7), 2003572 (2021)","DOI":"10.1002\/advs.202003572"},{"issue":"1","key":"25_CR27","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41467-023-39224-8","volume":"14","author":"D-H Nguyen","year":"2023","unstructured":"Nguyen, D.-H., et al.: Bioengineering of bacteria for cancer immunotherapy. Nat. Commun. 14(1), 3553 (2023)","journal-title":"Nat. Commun."},{"issue":"8","key":"25_CR28","doi-asserted-by":"crossref","first-page":"e0160926","DOI":"10.1371\/journal.pone.0160926","volume":"11","author":"RA Kazmierczak","year":"2016","unstructured":"Kazmierczak, R.A., et al.: Salmonella bacterial monotherapy reduces autochthonous prostate tumor burden in the TRAMP mouse model. PLoS One 11(8), e0160926 (2016)","journal-title":"PLoS ONE"},{"issue":"7882","key":"25_CR29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","volume":"598","author":"FP Canale","year":"2021","unstructured":"Canale, F.P., et al.: Metabolic modulation of tumours with engineered bacteria for immunotherapy. Nature 598(7882), 662\u2013666 (2021)","journal-title":"Nature"},{"key":"25_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.actbio.2021.02.006","volume":"124","author":"Y Chen","year":"2021","unstructured":"Chen, Y., et al.: Genetically engineered oncolytic bacteria as drug delivery systems for targeted cancer theranostics. Acta Biomater. 124, 72\u201387 (2021)","journal-title":"Acta Biomater."},{"key":"25_CR31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/IJN.S292432","volume":"16","author":"H Yang","year":"2021","unstructured":"Yang, H., et al.: Genetically engineered bacterial protein nanoparticles for targeted cancer therapy. Int. J. Nanomedicine 16, 105\u2013117 (2021)","journal-title":"Int. J. Nanomedicine"},{"issue":"12","key":"25_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","volume":"51","author":"MT-Q Duong","year":"2019","unstructured":"Duong, M.T.-Q., et al.: Bacteria-cancer interactions: bacteria-based cancer therapy. Exp. Mol. Med. 51(12), 1\u201315 (2019)","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"25_CR33","first-page":"310","volume":"11","author":"A Zhansaya","year":"2022","unstructured":"Zhansaya, A., et al.: Expression of recombinant CTLA-4 and PD-L1 proteins fused with thioredoxin, and determination of their ligand-binding activities. Rep. Biochem. Mol. Biol. 11(2), 310\u2013319 (2022)","journal-title":"Rep. Biochem. Mol. Biol."},{"key":"25_CR34","doi-asserted-by":"crossref","unstructured":"Gurbatri, C.R., et al.: Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci. Transl. Med. 12(530) (2020)","DOI":"10.1126\/scitranslmed.aax0876"},{"issue":"1","key":"25_CR35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/CVI.00274-08","volume":"16","author":"A Wallecha","year":"2009","unstructured":"Wallecha, A., et al.: Construction and characterization of an attenuated Listeria monocytogenes strain for clinical use in cancer immunotherapy. Clin. Vaccine Immunol. 16(1), 96\u2013103 (2009)","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"25_CR36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/IAI.00870-15","volume":"84","author":"KK Andersen","year":"2016","unstructured":"Andersen, K.K., et al.: Neutralization of clostridium difficile toxin B mediated by engineered lactobacilli that produce single-domain antibodies. Infect. Immun. 84(2), 395\u2013406 (2016)","journal-title":"Infect. Immun."},{"issue":"11\u201312","key":"25_CR37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3727\/096504001108747512","volume":"12","author":"X Luo","year":"2001","unstructured":"Luo, X., et al.: Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models. Oncol. Res. 12(11\u201312), 501\u2013508 (2001)","journal-title":"Oncol. Res."},{"issue":"20","key":"25_CR38","doi-asserted-by":"crossref","first-page":"33601","DOI":"10.18632\/oncotarget.16830","volume":"8","author":"SL Coutermarsh-Ott","year":"2017","unstructured":"Coutermarsh-Ott, S.L., et al.: Effect of Salmonella enterica serovar typhimurium VNP20009 and VNP20009 with restored chemotaxis on 4T1 mouse mammary carcinoma progression. Oncotarget 8(20), 33601\u201333613 (2017)","journal-title":"Oncotarget"},{"key":"25_CR39","doi-asserted-by":"crossref","first-page":"1253506","DOI":"10.3389\/fpubh.2023.1253506","volume":"11","author":"K Zhang","year":"2023","unstructured":"Zhang, K., et al.: Metabolic diseases and healthy aging: identifying environmental and behavioral risk factors and promoting public health. Front. Public Health 11, 1253506 (2023)","journal-title":"Front. Public Health"},{"issue":"2","key":"25_CR40","first-page":"e19","volume":"24","author":"SM Grundy","year":"2004","unstructured":"Grundy, S.M., et al.: Clinical management of metabolic syndrome: report of the American heart association\/national heart, lung, and blood institute\/American diabetes association conference on scientific issues related to management. Arterioscler. Thromb. Vasc. Biol. 24(2), e19\u201324 (2004)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"25_CR41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2023.02.003","volume":"35","author":"NWS Chew","year":"2023","unstructured":"Chew, N.W.S., et al.: The global burden of metabolic disease: data from 2000 to 2019. Cell Metab. 35(3), 414\u2013428.e3 (2023)","journal-title":"Cell Metab."},{"issue":"19","key":"25_CR42","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1021\/acs.jafc.5b01246","volume":"63","author":"Y Zhao","year":"2015","unstructured":"Zhao, Y., et al.: Carnosic acid as a major bioactive component in rosemary extract ameliorates high-fat-diet-induced obesity and metabolic syndrome in mice. J. Agric. Food Chem. 63(19), 4843\u20134852 (2015)","journal-title":"J. Agric. Food Chem."},{"key":"25_CR43","doi-asserted-by":"crossref","first-page":"100650","DOI":"10.1016\/j.scp.2022.100650","volume":"27","author":"KB Arun","year":"2022","unstructured":"Arun, K.B., et al.: Bacterial bioactive metabolites as therapeutic agents: from production to action. Sustainable Chem. Pharm. 27, 100650 (2022)","journal-title":"Sustainable Chem. Pharm."},{"issue":"5","key":"25_CR44","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/1751-7915.13398","volume":"12","author":"ON Sekurova","year":"2019","unstructured":"Sekurova, O.N., Schneider, O., Zotchev, S.B.: Novel bioactive natural products from bacteria via bioprospecting, genome mining and metabolic engineering. Microb. Biotechnol. 12(5), 828\u2013844 (2019)","journal-title":"Microb. Biotechnol."},{"issue":"3","key":"25_CR45","doi-asserted-by":"crossref","first-page":"e14001","DOI":"10.1111\/apha.14001","volume":"238","author":"D Ciocan","year":"2023","unstructured":"Ciocan, D., Elinav, E.: Engineering bacteria to modulate host metabolism. Acta Physiol (Oxf.) 238(3), e14001 (2023)","journal-title":"Acta Physiol (Oxf.)"},{"issue":"1","key":"25_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","volume":"57","author":"I Rowland","year":"2018","unstructured":"Rowland, I., et al.: Gut microbiota functions: metabolism of nutrients and other food components. Eur. J. Nutr. 57(1), 1\u201324 (2018)","journal-title":"Eur. J. Nutr."},{"key":"25_CR47","doi-asserted-by":"crossref","first-page":"718356","DOI":"10.3389\/fnut.2021.718356","volume":"8","author":"G Barbara","year":"2021","unstructured":"Barbara, G., et al.: Inflammatory and microbiota-related regulation of the intestinal epithelial barrier. Front. Nutr. 8, 718356 (2021)","journal-title":"Front. Nutr."},{"key":"25_CR48","doi-asserted-by":"crossref","first-page":"870675","DOI":"10.3389\/fbioe.2022.870675","volume":"10","author":"R Omer","year":"2022","unstructured":"Omer, R., et al.: Engineered bacteria-based living materials for biotherapeutic applications. Front. Bioeng. Biotechnol. 10, 870675 (2022)","journal-title":"Front. Bioeng. Biotechnol."},{"key":"25_CR49","doi-asserted-by":"crossref","unstructured":"Kurtz, C.B., et al.: An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci. Transl. Med. 11(475) (2019)","DOI":"10.1126\/scitranslmed.aau7975"},{"issue":"3","key":"25_CR50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.synbio.2018.09.001","volume":"3","author":"B Baral","year":"2018","unstructured":"Baral, B., Akhgari, A., Mets\u00e4-Ketel\u00e4, M.: Activation of microbial secondary metabolic pathways: avenues and challenges. Synth. Syst. Biotechnol. 3(3), 163\u2013178 (2018)","journal-title":"Synth. Syst. Biotechnol."},{"issue":"106","key":"25_CR51","doi-asserted-by":"crossref","first-page":"86954","DOI":"10.1039\/C5RA14892H","volume":"5","author":"P Kumar","year":"2015","unstructured":"Kumar, P., Dubey, K.K.: Current trends and future prospects of lipstatin: a lipase inhibitor and pro-drug for obesity. RSC Adv. 5(106), 86954\u201386966 (2015)","journal-title":"RSC Adv."},{"key":"25_CR52","doi-asserted-by":"crossref","unstructured":"Arya, A., et al., Chapter Thirteen - Anti-obesity natural products, In: Sarker, S.D., Nahar, L., (eds.) Annual Reports in Medicinal Chemistry, pp. 411\u2013433. Academic Press (2020)","DOI":"10.1016\/bs.armc.2020.02.006"},{"issue":"3","key":"25_CR53","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00125-019-05073-8","volume":"63","author":"PF de Groot","year":"2020","unstructured":"de Groot, P.F., et al.: Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial. Diabetologia 63(3), 597\u2013610 (2020)","journal-title":"Diabetologia"},{"issue":"1","key":"25_CR54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12934-020-01350-z","volume":"19","author":"L Bai","year":"2020","unstructured":"Bai, L., et al.: Engineered butyrate-producing bacteria prevents high fat diet-induced obesity in mice. Microb. Cell Fact. 19(1), 94 (2020)","journal-title":"Microb. Cell Fact."},{"issue":"10","key":"25_CR55","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","volume":"11","author":"EE Canfora","year":"2015","unstructured":"Canfora, E.E., Jocken, J.W., Blaak, E.E.: Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11(10), 577\u2013591 (2015)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"25_CR56","doi-asserted-by":"crossref","first-page":"2172671","DOI":"10.1080\/19490976.2023.2172671","volume":"15","author":"AB Larabi","year":"2023","unstructured":"Larabi, A.B., Masson, H.L.P., B\u00e4umler, A.J.: Bile acids as modulators of gut microbiota composition and function. Gut Microbes 15(1), 2172671 (2023)","journal-title":"Gut Microbes"},{"key":"25_CR57","doi-asserted-by":"crossref","first-page":"595575","DOI":"10.3389\/fcimb.2021.595575","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang, L., et al.: Engineered bacteria of MG1363-pMG36e-GLP-1 attenuated obesity-induced by high fat diet in mice. Front. Cell. Infect. Microbiol. 11, 595575 (2021)","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"25_CR58","doi-asserted-by":"crossref","first-page":"110890","DOI":"10.1016\/j.fct.2019.110890","volume":"135","author":"J Lu","year":"2020","unstructured":"Lu, J., et al.: Co-expression of alcohol dehydrogenase and aldehyde dehydrogenase in Bacillus subtilis for alcohol detoxification. Food Chem. Toxicol. 135, 110890 (2020)","journal-title":"Food Chem. Toxicol."},{"key":"25_CR59","doi-asserted-by":"crossref","unstructured":"Plavec, T.V., Berlec, A.: Safety aspects of genetically modified lactic acid bacteria. Microorganisms 8(2) (2020)","DOI":"10.3390\/microorganisms8020297"},{"key":"25_CR60","doi-asserted-by":"crossref","first-page":"8045646","DOI":"10.1155\/2020\/8045646","volume":"2020","author":"GA Ogunrinola","year":"2020","unstructured":"Ogunrinola, G.A., et al.: The human microbiome and its impacts on health. Int. J. Microbiol. 2020, 8045646 (2020)","journal-title":"Int. J. Microbiol."},{"key":"25_CR61","doi-asserted-by":"crossref","unstructured":"Muteeb, G., et al.: Origin of antibiotics and antibiotic resistance, and their impacts on drug development: a narrative review. Pharmaceuticals (Basel) 16(11) (2023)","DOI":"10.3390\/ph16111615"},{"key":"25_CR62","doi-asserted-by":"crossref","unstructured":"Yamin, D., et al.: Current and future technologies for the detection of antibiotic-resistant bacteria. Diagnostics (Basel) 13(20) (2023)","DOI":"10.3390\/diagnostics13203246"},{"key":"25_CR63","doi-asserted-by":"crossref","unstructured":"Brennan, A.M.: Development of synthetic biotics as treatment for human diseases. Synth. Biol. (Oxf.) 7(1), ysac001 (2021)","DOI":"10.1093\/synbio\/ysac001"},{"issue":"1","key":"25_CR64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","volume":"7","author":"K Hou","year":"2022","unstructured":"Hou, K., et al.: Microbiota in health and diseases. Signal Transduct. Target. Ther. 7(1), 135 (2022)","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Lecture Notes in Computer Science","Bioinformatics and Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-64636-2_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:08:39Z","timestamp":1728986919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-64636-2_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031646355","9783031646362"],"references-count":64,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-64636-2_25","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"28 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"IWBBIO","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Work-Conference on Bioinformatics and Biomedical Engineering","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Gran Canaria","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Spain","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2024","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"15 July 2024","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"17 July 2024","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"11","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iwbbio2024","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/iwbbio.ugr.es\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}